Following a lengthy period trading at a single digit price to earnings multiple, Navigator Global Investments has started to ...
Yao Pharma’s deal with the US pharmaceutical giant underscores China’s growing role in global biotech licensing.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback